Official SEC submissions

ArriVent BioPharma SEC Filings

Direct answer

ArriVent BioPharma's latest SEC filing is 10-Q.

It was filed on August 12, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free ArriVent BioPharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

10-Q

Periodic report

Filed: 2026-08-12

Report date: 2026-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-12

Report date: 2026-08-11

FORM 8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-06-22

Report date: 2026-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-22

Report date: 2026-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-22

Report date: 2026-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-06-22

Report date: 2026-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-22

Report date: 2026-06-18

FORM 8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-11

Report date: 2026-05-11

FORM 8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-11

Report date: 2026-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-11

Report date: 2026-05-11

8-K

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-04-28

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-04-28

Report date: 2026-06-18

FORM- DEF 14A

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-17

Report date: 2026-03-17

8-K

Open SEC document View filing index

10-K

Periodic report

Filed: 2026-03-05

Report date: 2025-12-31

10-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-05

Report date: 2026-03-05

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-02-04

Report date: 2026-02-02

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-02-04

Report date: 2026-02-02

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-02-04

Report date: 2026-02-02

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-02-04

Report date: 2026-02-02

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-02-04

Report date: 2026-02-02

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2026-02-03

Report date: 2025-12-10

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-11-10

Report date: 2025-09-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-10

Report date: 2025-11-10

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-09-09

Report date: 2025-09-09

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-08-11

Report date: 2025-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-08-11

Report date: 2025-08-11

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-07-21

Report date: 2025-07-21

FORM 8-K

Open SEC document View filing index

Insider transaction

Filed: 2025-07-15

Report date: 2025-07-11

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2025-07-02

Report date: 2025-07-01

FORM 8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-06-23

Report date: 2025-06-23

FORM 8-K

Open SEC document View filing index

Insider transaction

Filed: 2025-06-20

Report date: 2025-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2025-06-20

Report date: 2025-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2025-06-20

Report date: 2025-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

Insider transaction

Filed: 2025-06-20

Report date: 2025-06-18

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2025-06-20

Report date: 2025-06-18

FORM 8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-05-12

Report date: 2025-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-05-12

Report date: 2025-05-12

8-K

Open SEC document View filing index

Insider transaction

Filed: 2025-04-29

Report date: 2025-04-28

OWNERSHIP DOCUMENT

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-04-28

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2025-04-28

Report date: 2025-06-18

DEF 14A

Open SEC document View filing index

Verified data

Recent filing categories: 4
Recent filings: 40
SEC CIK: 0001868279
Latest filing date: August 12, 2026

Explore related company data

View the ArriVent BioPharma company profile View ArriVent BioPharma annual financials